CD34 and graft versus host disease: Furthermore, it has been noted that the composition of graft cells, specifically the ratio of CD34+ HSCs to CD3+ T-cells, can significantly impact the success of engraftment and the incidence of graft-versus-host disease (GVHD) [6].